John E Herrmann

Title: John E Herrmann: Innovator in Immunoassay Technology

Introduction

John E Herrmann is a notable inventor based in Hawthorn Woods, IL (US). He has made significant contributions to the field of immunoassays, particularly in the detection of specific antigens related to infectious diseases. With a total of 2 patents, Herrmann's work has implications for clinical diagnostics and public health.

Latest Patents

Herrmann's latest patents include innovative methods for detecting Chlamydia trachomatis and Neisseria gonorrhoeae antigens. The first patent, titled "Immunoassay for Chlamydia trachomatis antigens," describes a solid phase immunoassay designed to identify Chlamydia trachomatis antigens in clinical specimens. The second patent, "Immunoassay for Neisseria gonorrhoeae antigens," outlines a similar approach for detecting Neisseria gonorrhoeae antigens, also utilizing a solid phase for the determination of these antigens.

Career Highlights

John E Herrmann is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on developing advanced diagnostic tools that enhance the accuracy and efficiency of disease detection.

Collaborations

Throughout his career, Herrmann has collaborated with esteemed colleagues, including Alan S Armstrong and Lawrence V Howard. These partnerships have contributed to the advancement of immunoassay technologies and have fostered innovation within the field.

Conclusion

John E Herrmann's contributions to immunoassay technology exemplify the impact of innovative thinking in healthcare. His patents not only advance diagnostic capabilities but also play a crucial role in improving patient outcomes.